Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiopulmonary exercise testing in Fabry disease.

Gregory Bierer1, Nader Kamangar, David Balfe

  • 1Division of Pulmonary/Critical Care Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. BiererG@cshs.org

Respiration; International Review of Thoracic Diseases
|October 8, 2005
PubMed
Summary

Patients with Fabry disease experience a significant drop in diastolic blood pressure during exercise, potentially explaining reduced exercise tolerance. This finding is notable in female patients, highlighting a key aspect of Fabry disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CT findings in biomass smoke-associated interstitial lung disease: A retrospective analysis.

Journal of clinical imaging science·2026
Same author

Long-term efficacy and safety of pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease: results from up to 5 years of the BRIGHT F51 phase III, open-label extension study.

Orphanet journal of rare diseases·2026
Same author

Silicosis Epidemic among Engineered Stone Countertop Workers: Pictorial Review.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026
Same author

Historical Control Analysis Demonstrates Greater Long-Term Reduction in Plasma Globotriaosylceramide (Gb3) by Venglustat Compared With Placebo or Agalsidase Beta in Male Patients With Classic Fabry Disease.

Molecular genetics & genomic medicine·2025
Same author

Clinical Decision Support Aiming to Accelerate Triage and Time to Dextrose-Containing IV Fluids in the ED for Children with Severe Metabolic Conditions.

Applied clinical informatics·2025
Same author

Implementation and evaluation of the 3 Wishes Project in safety-net hospitals: Protocol for a hybrid effectiveness-implementation study.

PloS one·2025

Area of Science:

  • Cardiopulmonary physiology
  • Rare genetic disorders
  • Lysosomal storage diseases

Background:

  • Fabry disease is an X-linked disorder caused by alpha-galactosidase A deficiency, leading to globotriaosylceramide accumulation.
  • Clinical manifestations include angiokeratomas, acroparesthesias, hypohidrosis, and potential progression to organ failure.
  • Patients often report decreased exercise tolerance and fatigue.

Purpose of the Study:

  • To evaluate the cardiopulmonary characteristics of Fabry disease patients.
  • To assess physiological responses at rest and during exercise.

Main Methods:

  • A cohort of 39 Fabry disease patients underwent comprehensive health screening.
  • Tests included electrocardiogram, echocardiogram, spirometry, and cardiopulmonary exercise testing.

Related Experiment Videos

  • A control group was included for comparative analysis.

    • Main Results:

    • 46% of Fabry patients showed a significant decrease in diastolic blood pressure (DBP) during exercise (average 10 mm Hg drop).
    • A notable drop in DBP was observed in 38% of female patients.
    • No significant DBP drop occurred in the control group.

    Conclusions:

    • A significant exercise-induced DBP decrease in Fabry disease may contribute to exercise intolerance.
    • This hemodynamic abnormality is present in female patients, despite generally milder disease presentation.
    • Further research into exercise limitations in Fabry disease is warranted.